Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation

Tag: ivermectin

September 7, 2021 Drug delivery / Pharma applications

Use of ivermectin in the treatment of Covid-19: A pilot trial

As repurposing ivermectin against Covid-19 is still in the focus of debates and as this drug can be formulated with

Continue reading

August 2, 2021 Drug delivery / Pharma applications

Safety of inhaled HPBCD-formulated ivermectin as a repurposed direct drug for treatment of COVID-19: A preclinical tolerance study

SARS-CoV-2 replication in cell cultures has been shown to be inhibited by ivermectin. However, ivermectin’s low aqueous solubility and bioavailability hinders

Continue reading

March 16, 2021 Drug delivery / Pharma applications

Remdesivir-Ivermectin combination displays synergistic interaction with improved in vitro antiviral activity against SARS-CoV-2

Drug combination strategies of repurposed drugs offer a number of advantages to monotherapies including the potential to achieve greater efficacy,

Continue reading

October 9, 2020 Drug delivery / Pharma applications

Ivermectin against COVID-19

Ivermectin is a medication used to treat a number of parasite infections. Chemically, this compound and derivatives are macrocyclic lactones

Continue reading

Recent Posts

  • New Trends in Cyclodextrins Technology for Pharmaceutical
  • The Cyclodextrin Wall of Pride: Who Are the Top-Cited Cyclodextrin Scientists?
  • Over 70,000 hits in Scopus for “cyclodextrin” keyword
  • Pivotal Phase 3 TransportNPC™ Study of Trappsol® Cyclo™ in Niemann-Pick Disease Type C (NPC) concluded
  • Eco-Friendly Nanoantibiotics: A New Approach to Combat Resistance

Tags

alpha-CD atherosclerosis Cancer therapy Captisol Cholesterol Clinical trial conference Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems electrospinning FDA Food gamma-CD Gilead HPBCD hydrogel methyl BCD Nanoparticles Niemann Pick Disease RAMEB remdesivir review SBECD Special issue Sugammadex Synthesis

Follow Us

  • LinkedIn
  • X
  • Facebook

Categories

  • Agriculture (28)
  • Analysis (74)
  • CD as API (359)
  • CD derivatives (437)
  • Cosmetics and toilettry (54)
  • Diagnosis (15)
  • Drug delivery (821)
  • E-ducation (64)
  • Environmental (144)
  • Events (242)
  • Food (237)
  • Gene delivery (22)
  • Household products (6)
  • In Hungarian (4)
  • Life sciences (46)
  • Non-pharma applications (421)
  • Other industrial use (113)
  • Pharma applications (1,227)
  • Supramolecular systems (44)
  • Uncategorized (170)

Top Posts

  • The Cyclodextrin Wall of Pride: Who Are the Top-Cited Cyclodextrin Scientists?
  • New Trends in Cyclodextrins Technology for Pharmaceutical
  • Nobel prize in chemistry in regard of cyclodextrin chemistry and application
  • Pivotal Phase 3 TransportNPC™ Study of Trappsol® Cyclo™ in Niemann-Pick Disease Type C (NPC) concluded
  • Eco-Friendly Nanoantibiotics: A New Approach to Combat Resistance
  • Cyclodextrin Produced In situ: Rethinking Oat Milk Design for Better Performance
  • HPBCD is a unique component in Janssen's COVID-19 vaccine candidate
  • Over 70,000 hits in Scopus for "cyclodextrin" keyword
  • Application of cyclodextrins for detoxification purposes and/or as antidotes: Still more questions than answers
  • CD-enabled active food packaging in the recent literature

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 4,470 other subscribers
Loading Comments...